Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
28 Ergebnisse
| MG15FU |  | Neurocrine Biosciences Inc./Faktor/Long [2]/MS | - | - | call | Neurocrine Biosciences Inc. | 86,365 | 86,365 | 2,009 | 50,408 % | - | Morgan Stanley | |
| MJ0E7T | | Neurocrine Biosciences Inc./Faktor/Long [3]/MS | - | - | call | Neurocrine Biosciences Inc. | 115,153 | 115,153 | 3,058 | 33,877 % | - | Morgan Stanley | |
| MJ6KEQ | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 82,899 | 91,960 | 1,888 | 47,195 % | - | Morgan Stanley | |
| MK4AZW | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 67,022 | 67,022 | 1,606 | 61,515 % | - | Morgan Stanley | |
| MK4C1R | | Neurocrine Biosciences Inc./Faktor/Long [3]/MS | - | - | call | Neurocrine Biosciences Inc. | 115,153 | 115,153 | 3,066 | 33,877 % | - | Morgan Stanley | |
| MK5EAV | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 89,056 | 89,056 | 2,017 | 48,863 % | - | Morgan Stanley | |
| MK6B42 | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 110,912 | 110,912 | 2,753 | 36,312 % | - | Morgan Stanley | |
| MK6WQ6 | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 99,773 | 110,680 | 2,316 | 36,446 % | - | Morgan Stanley | |
| MM1ZCE | | Neurocrine Biosciences Inc./Faktor/Long [4]/MS | - | - | call | Neurocrine Biosciences Inc. | 129,547 | 129,547 | - | 25,612 % | - | Morgan Stanley | |
| MM1ZCF | | Neurocrine Biosciences Inc./Faktor/Long [5]/MS | - | - | call | Neurocrine Biosciences Inc. | 138,183 | 138,183 | - | 20,653 % | - | Morgan Stanley | |
| MM1ZCG | | Neurocrine Biosciences Inc./Faktor/Long [8]/MS | - | - | call | Neurocrine Biosciences Inc. | 151,138 | 151,138 | - | 13,214 % | - | Morgan Stanley | |
| MM1ZCH | | Neurocrine Biosciences Inc./Faktor/Long [10]/MS | - | - | call | Neurocrine Biosciences Inc. | 155,456 | 155,456 | - | 10,734 % | - | Morgan Stanley | |
| MM20H2 | | Neurocrine Biosciences Inc./Faktor/Short [5]/MS | - | - | put | Neurocrine Biosciences Inc. | 207,223 | 207,223 | - | 18,991 % | - | Morgan Stanley | |
| MM3TGR | | Neurocrine Biosciences Inc./KO/Put [endlos]/MS | - | - | put | Neurocrine Biosciences Inc. | 198,742 | 198,742 | - | 14,121 % | - | Morgan Stanley | |
| MN11NQ | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 75,249 | 83,470 | 1,745 | 52,070 % | - | Morgan Stanley | |
| MN4HCE | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 111,627 | 123,830 | 2,733 | 28,895 % | - | Morgan Stanley | |
| MN8PJF | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 122,346 | 122,346 | - | 29,747 % | - | Morgan Stanley | |
| MN8PXN | | Neurocrine Biosciences Inc./Faktor/Long [8]/MS | - | - | call | Neurocrine Biosciences Inc. | 151,138 | 151,138 | - | 13,214 % | - | Morgan Stanley | |
| MN8PXP | | Neurocrine Biosciences Inc./Faktor/Long [10]/MS | - | - | call | Neurocrine Biosciences Inc. | 155,456 | 155,456 | - | 10,734 % | - | Morgan Stanley | |
| MN8Q42 | | Neurocrine Biosciences Inc./Faktor/Short [4]/MS | - | - | put | Neurocrine Biosciences Inc. | 215,857 | 215,857 | - | 23,949 % | - | Morgan Stanley | |
| MN8Q43 | | Neurocrine Biosciences Inc./Faktor/Short [8]/MS | - | - | put | Neurocrine Biosciences Inc. | 194,271 | 194,271 | - | 11,554 % | - | Morgan Stanley | |
| MN8Q44 | | Neurocrine Biosciences Inc./Faktor/Short [10]/MS | - | - | put | Neurocrine Biosciences Inc. | 189,954 | 189,954 | - | 9,075 % | - | Morgan Stanley | |
| MN96CX | | Neurocrine Biosciences Inc./Faktor/Long [1,5]/MS | - | - | call | Neurocrine Biosciences Inc. | 57,576 | 57,576 | - | 66,939 % | - | Morgan Stanley | |
| MN9L0F | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 128,187 | 142,200 | 3,699 | 18,346 % | - | Morgan Stanley | |
| MR2RTZ | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 140,727 | 140,727 | - | 19,192 % | - | Morgan Stanley | |
| MR3G22 | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 144,663 | 160,470 | - | 7,855 % | - | Morgan Stanley | |
| MR3HS1 | | Neurocrine Biosciences Inc./Faktor/Short [2]/MS | - | - | put | Neurocrine Biosciences Inc. | 259,029 | 259,029 | - | 48,739 % | - | Morgan Stanley | |
| MR3HS2 | | Neurocrine Biosciences Inc./Faktor/Short [3]/MS | - | - | put | Neurocrine Biosciences Inc. | 230,248 | 230,248 | - | 32,212 % | - | Morgan Stanley |